Literature DB >> 17562067

Bilateral cystoid macular edema in a patient with chronic myeloid leukaemia under treatment with imanitib mesylate: report of an unusual side effect.

Ilias Georgalas, Carlos Pavesio, Eric Ezra.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17562067     DOI： 10.1007/s00417-007-0600-y

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN： 0721-832X            Impact factor:   3.117


× No keyword cloud information.
  5 in total

1.  Visual disturbance due to retinal edema as a complication of imatinib.

Authors:  E Kusumi; A Arakawa; M Kami; D Kato; K Yuji; Y Kishi; N Murashige; S Miyakoshi; J Ueyama; S Morinaga; S Taniguchi; Y Muto
Journal:  Leukemia       Date:  2004-06       Impact factor: 11.528

Review 2.  Perspectives on the treatment of chronic phase and advanced phase CML and Philadelphia chromosome positive ALL(1).

Authors:  C A Schiffer; R Hehlmann; R Larson
Journal:  Leukemia       Date:  2003-04       Impact factor: 11.528

3.  Platelet-derived growth factor ligands and receptors immunolocalized in proliferative retinal diseases.

Authors:  S G Robbins; R N Mixon; D J Wilson; C E Hart; J E Robertson; I Westra; S R Planck; J T Rosenbaum
Journal:  Invest Ophthalmol Vis Sci       Date:  1994-09       Impact factor: 4.799

4.  Ocular side-effects associated with imatinib mesylate (Gleevec).

Authors:  Frederick W Fraunfelder; Jonathan Solomon; Brian J Druker; Bita Esmaeli; Jennifer Kuyl
Journal:  J Ocul Pharmacol Ther       Date:  2003-08       Impact factor: 2.671

5.  Imatinib as a cause of cystoid macular edema following uneventful phacoemulsification surgery.

Authors:  Imran Masood; Anil Negi; Harminder S Dua
Journal:  J Cataract Refract Surg       Date:  2005-12       Impact factor: 3.351
  5 in total
  5 in total

1.  Periorbital edema secondary to imatinib mesylate.

Authors:  Collin M McClelland; George J Harocopos; Philip L Custer
Journal:  Clin Ophthalmol       Date:  2010-05-14

Review 2.  Neuro-ophthalmic side effects of molecularly targeted cancer drugs.

Authors:  M T Bhatti; A K S Salama
Journal:  Eye (Lond)       Date:  2017-10-20       Impact factor: 3.775

Review 3.  Drug-induced macular edema.

Authors:  Olga E Makri; Ilias Georgalas; Constantine D Georgakopoulos
Journal:  Drugs       Date:  2013-06       Impact factor: 9.546

Review 4.  Ocular Toxicity of Targeted Anticancer Agents.

Authors:  Blake H Fortes; Prashant D Tailor; Lauren A Dalvin
Journal:  Drugs       Date:  2021-03-31       Impact factor: 9.546

5.  Intravitreal bevacizumab and triamcinolone for treatment of cystoid macular oedema associated with chronic myeloid leukaemia and imatinib therapy.

Authors:  Eric K Newcott; Abdallah A Ellabban; Shokufeh Tavassoli; Ahmed Sallam
Journal:  Case Rep Ophthalmol Med       Date:  2015-02-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.